Newsletter
In this section, you will find the lastest news about our products
LymphoSign CE-IVD: Workflow and Specifications for NHL Diagnostics
The LymphoSign CE-IVD Kit enables classification of over 80 Non-Hodgkin’s lymphoma (NHL) subtypes through RT-MLPSeq analysis of more than 130 genetic markers. This CE-marked diagnostic tool features a 4-step RNA-to-result workflow compatible with FFPE samples and Illumina sequencers, supported by AI-driven RT-MIS software referencing 3,000+ tumor profiles.
 |
RT-MLPSEQ: A new technology to characterize cancers, Gene expression and fusion transcripts
This solution allows you to assess the mRNA expression level or the presence of fusion transcripts of 10 to 100 markers of interest of your choice.
|
LymphoSign : CE/IVD kit for the classification of non-Hodgkin's lymphomas
The LymphoSign Kit, plays a crucial role in establishing accurate diagnoses and treatment plans for non-Hodgkin’s lymphoma. Leveraging RNA expression levels from over 130 relevant gene markers, this state-of-the-art method provides valuable insights into disease progression. Its simple, fast protocol and suitability for challenging samples make it a powerful tool in non-Hodgkin’s lymphoma research and patient care .
|